CARE Program for Oncology™
Ambry Genetics®, part of Konica Minolta Precision Medicine, developed the CARE (Comprehensive, Assessment, Risk, and Education) Program™. The CARE Program provides clinically actionable results to healthcare professionals to inform cancer screening and prevention, and effectively communicates this information to patients and their care teams.
Benefits of the Program
- >Provides personalized cancer risk information
- >Facilitates recommendations for additional screening
- >Identifies at-risk family members
- >Integrates seamlessly into your workflow
- >Helps reduce missed patients across clinics and providers
Learn More
Why Choose the CARE for Oncology Program?
Genetic testing should be offered to more individuals with suspected inherited cancer risk, but it also needs to be managed in an effective and efficient way. The CARE for Oncology Program streamlines this entire process so the focus can be on helping patients and providing accurate results, not time-consuming paperwork and communications logistics. Manage patient information between healthcare providers, clinics and genetic counselors in an all-in-one efficient platform.
For Your Patients Who May Be At Risk
The CARE for Oncology Program provides a complete platform for managing patients and their results:
- Streamlined screening assessment to identify those at risk
- Pre-test education and genetic testing services
- Results received directly through the platform
- Post-test counseling to those who qualify
We Offer a Unique End-to-End Solution to Identify High-Risk Patients
Early Detection and Prevention are Critical
There are numerous professional society guidelines indicating that genetic testing for hereditary cancer is an important part of medical care. The National Comprehensive Cancer Network® (NCCN®) states that “Genetic testing should be considered in appropriate high-risk individuals where it will impact the medical management of the tested individuals and/or their at-risk family members.”
The American Society of Clinical Oncology (ASCO) recommends that “genetic testing be offered to individuals with suspected inherited (genetic) cancer risk in situations where test results can be interpreted, and when they affect medical management of the patient.”1
Did You Know?
FAQs
Q: What is the cost to patients for genetic testing?
A: Through the CARE for Oncology Program, eligible patients will receive genetic testing through Ambry Genetics. Due to Ambry’s extensive contracts with commercial payers (covering 95% of insured lives), testing is affordable and accessible for the majority of patients. Four out of five patients pay $0 and for those who do pay, they pay on average less than $100. For additional questions on billing, please contact Ambry at 949.900.5500 or billing@ambrygen.com.
Q: Which patients will receive genetic testing?
A: A patient’s personal and family history of cancer will be evaluated to determine if they are eligible for hereditary cancer genetic testing. Our program uses National Comprehensive Cancer Network (NCCN) genetic testing criteria, which outline various factors that may indicate a need for genetic testing, such as type of cancer, age of diagnosis, and number of family members with cancer. Any patient who meets these criteria will be offered genetic testing.
Contact us to receive
our full FAQ sheet
1. ascopubs.org/doi/10.1200/JCO.2015.63.0996
2. Z. Kakushadze, et al, in September 2017-Cornell University
